To top
Unité
LUDGER JOHANNES / CHRISTOPHE LAMAZE
Chimie et Biologie de la Cellule (UMR3666 / U1143)

L’Institut Curie est un centre de recherche et de traitement du cancer marqué par l’interdisciplinarité. L'unité ''Chimie et Biologie de la Cellule'' tient à cet esprit en réunissant au sein du même périmètre des chercheurs de divers horizons, notamment la chimie organique et la biologie cellulaire.

Chiffres-clés
11
Prix/honneurs
2
ERC
21
Publications avec IF>20
Publications clés
Toutes les publications
Actualités
Toutes les actualités
Événements scientifiques
28 avr
2023
Séminaire
11h-23h
Centre de recherche - Paris - Amphithéâtre Marie Curie
Modern fluorophores and hypoxia targeting
Hypoxia (low oxygen levels) occurs in a range of biological contexts, including plants, bacterial biofilms, and solid tumors. It elicits responses from these biological systems that impact their survival, for example, hypoxia makes tumors more resistant to all forms of therapy and leads to poor patient prognosis. Furthermore, hypoxia in the tumor microenvironment is heterogeneous (with O2 ranging
12 jan
2023
13 jan
2023
Evénement
08h-19h
Centre de recherche - Paris - Amphithéâtre Constant-Burg - 12 rue Lhomond, Paris 5e
3rd PSL Chemical Biology Symposium
The 3rd PSL Chemical Biology symposium will take place in Paris at Institut Curie, from January 12-13, 2023. 

An international meeting organized by Institut Curie, Chimie PSL University, Sorbonne University, Inserm and CNRS.

For the 3rd PSL Chemical Biology Symposium, the state of the art in chemical biology will again be presented by world leaders to feature the latest innovations
9 Sep
2022
Séminaire
10h-23h
Centre de recherche - Paris - Amphithéâtre Constant-Burg - 12 rue Lhomond, Paris 5e
Targeting chromatin regulators in cancer
A hallmark of all malignancies is transcriptional dysregulation, which is initiated by recurrent translocations and/or mutations in transcription factors and chromatin regulators. These genetic aberrations manifests as a block in differentiation and an increase in malignant self-renewal. They also facilitate the cancer’s ability to adapt rapidly to therapeutic pressure. These established fea
Tous les événements scientifiques
Offres d'emploi
Aucune offre d'emploi disponible.
Toutes les offres